MGTX · Company research

MeiraGTx Holdings plc Ordinary Shares (MGTX): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily(MGTX) Movement Within Algorithmic Entry Frameworks Stock Traders DailyView source ↗Stock Traders DailyOct 17, 2026neutral00.6
MeiraGTx Holdings (MGTX) Pulls Back On Valuation Focus, Is The Stock Still Cheap? - Simply Wall StreetMeiraGTx Holdings (MGTX) Pulls Back On Valuation Focus, Is The Stock Still Cheap? Simply Wall StreetView source ↗Simply Wall StreetOct 12, 2026neutral00.6
Officer Stuart Naylor proposes selling 27,659 MeiraGTx (NASDAQ: MGTX) shares worth $294K. - Stock TitanOfficer Stuart Naylor proposes selling 27,659 MeiraGTx (NASDAQ: MGTX) shares worth $294K. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
Meiragtx Holdings Plc (MGTX-Q) Stock Price and News - The Globe and MailMeiragtx Holdings Plc (MGTX-Q) Stock Price and News The Globe and MailView source ↗The Globe and MailOct 1, 2026neutral00.6
MeiraGTx (MGTX) Stock Could Look Stretched As Earnings Face Questions - Simply Wall StreetMeiraGTx (MGTX) Stock Could Look Stretched As Earnings Face Questions Simply Wall StreetView source ↗Simply Wall StreetSep 24, 2026neutral00.6
A 100,000-unit share award for MeiraGTx (MGTX) director Alan Sebulsky vests over three years. - Stock TitanA 100,000-unit share award for MeiraGTx (MGTX) director Alan Sebulsky vests over three years. Stock TitanView source ↗Stock TitanSep 24, 2026neutral00.6
An investor who led a team overseeing over $2 billion in drug-company assets joins MeiraGTx's board. - Stock TitanAn investor who led a team overseeing over $2 billion in drug-company assets joins MeiraGTx's board. Stock TitanView source ↗Stock TitanSep 23, 2026neutral00.6
MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen - ChartMillMeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen ChartMillView source ↗ChartMillAug 21, 2026neutral00.6
MeiraGTx (MGTX) Stock Jumps After Profit Shock Raises Durability Questions - Simply Wall StreetMeiraGTx (MGTX) Stock Jumps After Profit Shock Raises Durability Questions Simply Wall StreetView source ↗Simply Wall StreetAug 14, 2026neutral00.6
Insider Sale: CFO & COO of $MGTX Sells 56,000 Shares - Quiver QuantitativeInsider Sale: CFO & COO of $MGTX Sells 56,000 Shares Quiver QuantitativeView source ↗Quiver QuantitativeJul 22, 2026neutral00.6
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? - Yahoo FinanceMeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? Yahoo FinanceView source ↗Yahoo FinanceJul 8, 2026neutral00.6
MeiraGTx wins $400M investment from Oberland (MGTX:NASDAQ) - Seeking AlphaMeiraGTx wins $400M investment from Oberland (MGTX:NASDAQ) Seeking AlphaView source ↗Seeking AlphaJul 7, 2026neutral00.6
MGTX Forecast — Price Target — Prediction for 2027 - TradingViewMGTX Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint - Yahoo FinanceCan MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint Yahoo FinanceView source ↗Yahoo FinanceMay 20, 2026neutral00.6
MeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo FinanceMeiraGTx (MGTX) Soars 6.8%: Is Further Upside Left in the Stock? Yahoo FinanceView source ↗Yahoo FinanceApr 20, 2026neutral00.6
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - qz.comStrength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? qz.comView source ↗qz.comMar 31, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.